Delivers a precise snapshot of any business with verified data.
Provides in-depth & verified financial insights of any company.
Offers a complete data-driven assessment of a business’s identity, creditworthiness and risk profile.
We've just released an update!
Check out the all new dashboard view. Pages now load faster.
Learn more
Delivers a precise snapshot of any business with verified data.
Provides in-depth & verified financial insights of any company.
Offers a complete data-driven assessment of a business’s identity, creditworthiness and risk profile.
Reveals legal history and leadership structure for decisive actions.
Delivers powerful peer comparisons, financial ratios, industries, location and much more...
We've just released an update!
Check out the all new dashboard view. Pages now load faster.
Learn more
Don’t miss any of our insights
Explore industry and country updates, business trends, or download free reports to help guide your company to success.
See All
Provide latest Country Reports that includes key aspect of a nation
Delivers insights into market trends, key players, competitive dynamics.
Provides business news on companies includes corporate actions...
Don’t miss any of our insights
Explore industry and country updates, business trends, or download free reports to help guide your company to success.
See All
HATINH PHARMACEUTICAL JOINT STOCK COMPANY
Active
Business ID 3000104879
84-239 / 3858 115 / 3858 447 / 3854 398
HATINH PHARMACEUTICAL JOINT STOCK COMPANY
Active
Business ID 3000104879
84-239 / 3858 115 / 3858 447 / 3854 398
HATINH PHARMACEUTICAL JOINT STOCK COMPANY
ActiveThe company operates as publicly held company. The sales of the subject company are downtrend, while the CAGR for the manufacture of pharmaceuticals, medicinal chemical and botanical products sector has been decreasing 2.80% in recent years.
+ LE H.P
+ LE Q.K
+ NGUYEN D.P
+ VO D.N
+ PHAM V.K
-2.80%
-5.39%
1,847
0.0637%
Purchase the report to access company details.
| Assets | -2.22% |
| Owner’s Equity | -50.21% |
| Working Capital | -40.65% |
| Net Worth | 21.53% |
| Sales | -53.76% |
| Operating income | 33.46% |
| EBIT | 36.15% |
| Gross Profit Margin | -73.24% |
| Debt to EBITDA | -55.07% |
Company Profile Report
Legal Profile
Contact and Location
Legal Representative
Shareholders
Business Operation
Assets
Owner's Equity
Sales
Profit
Company Standard Report
Legal Profile
Business Locations (on request only)
Legal Representative
EBT
EBITDA
Working Capital
Tangible Net Worth
Financial Ratios
Balance Sheet
Profit and Loss Statement
Cash Flow Statement
Comprehensive Report
Report Summary
Legal Profile
Historical Information
Business Locations
Subsidiary and Affiliated Company
Management and Directors
Shareholders
Business Operation
Suppliers
Buyers
Credit Limit
Industry Information
Key Industry Players
Competitors
Negative Payment Records
Banking Information
Litigation Records; Negative News
Financial Ratios
Balance Sheet
Profit and Loss Statement
Cash Flow Statement
Opinion from Analysts
GET IN TOUCH FOR EXCLUSIVE DEALS!
Contact Us
When did HATINH PHARMACEUTICAL JSC start operating?
What industry does HATINH PHARMACEUTICAL JSC operate in?
How can I contact HATINH PHARMACEUTICAL JSC?
What adverse news is there about HATINH PHARMACEUTICAL JSC?
What is stock symbol of HATINH PHARMACEUTICAL JSC?
Where is the location of HATINH PHARMACEUTICAL JSC?
What is HATINH PHARMACEUTICAL JSC’s business registration?
Let us be your
information partner
Partner with VNBIS for reliable, verified and up to date information